Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
Doody KM, Stanford SM, Sacchetti C, Svensson MN, Coles CH, Mitakidis N, Kiosses WB, Bartok B, Fos C, Cory E, Sah RL, Liu-Bryan R, Boyle DL, Arnett HA, Mustelin T, Corr M, Esko JD, Tremblay ML, Firestein GS, Aricescu AR, Bottini N.
Doody KM, et al. Among authors: arnett ha.
Sci Transl Med. 2015 May 20;7(288):288ra76. doi: 10.1126/scitranslmed.aaa4616.
Sci Transl Med. 2015.
PMID: 25995222
Free PMC article.